Active: Warfarin dose variability Clear all

GWAS 2021-11-02

Genomewide association analysis of warfarin dose requirements in Middle Eastern and North African populations.

El Rouby N, Shahin MH et al.

Clin Transl Sci

To date, there has been no genomewide association study (GWAS) from the Middle East and North Africa...

Warfarin dose variability

Replicated

182

Participants

N/A

Studies

Details PubMed

GWAS 2017-07-07

Influence of common and rare genetic variation on warfarin dose among African-Americans and European-Americans using the exome array.

Liu N, Irvin MR et al.

Pharmacogenomics

Aim: We conducted a genome-wide association study using the Illumina Exome Array to identify coding ...

Warfarin maintenance dose (adjusted for clinical factors)

Replicated

1707

Participants

N/A

Studies

Details PubMed

GWAS 2013-06-05

Genetic variants associated with warfarin dose in African-American individuals: a genome-wide association study.

Perera MA, Cavallari LH et al.

Lancet

VKORC1 and CYP2C9 are important contributors to warfarin dose variability, but explain less variabil...

Warfarin maintenance dose

Replicated

965

Participants

N/A

Studies

Details PubMed

Title

Author

Journal

Disease/Trait

Date

Actions

Genomewide association analysis of warfarin dose requirements in Middle Eastern and North African populations.

El Rouby N, Shahin MH et al.

Clin Transl Sci

Warfarin dose variability

2021-11-02

Influence of common and rare genetic variation on warfarin dose among African-Americans and European-Americans using the exome array.

Liu N, Irvin MR et al.

Pharmacogenomics

Warfarin maintenance dose (adjusted for clinical factors)

2017-07-07

Genetic variants associated with warfarin dose in African-American individuals: a genome-wide association study.

Perera MA, Cavallari LH et al.

Lancet

Warfarin maintenance dose

2013-06-05